Pluribus Labs’s AssetMark Financial Holdings, Inc. AMK Stock Holding History

Pluribus Labs’s Portfolio AMK Stock Details AMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-14,191	Closed	-$372K	–	234
2021 Q4	$372K	Buy	+14,191	New	+$367K	0.39%	93

Other funds holding AMK

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Pluribus Labs's AMK Position: Q1 2022 in Review

Pluribus Labs sold out of AssetMark Financial Holdings, Inc. (AMK) in Q1 2022, closing a stake of 14,191 shares — an estimated $372K sold.

Pluribus Labs first reported a position in AMK in Q4 2021 and held it in 1 quarter. The position peaked at $372K in Q4 2021. 87 funds tracked by Wall St. Rank hold AMK as of Q1 2022.

Pluribus Labs reported no remaining AssetMark Financial Holdings, Inc. position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 14,191 AssetMark Financial Holdings, Inc. shares in Q1 2022, an estimated $372K.
Pluribus Labs first reported a position in AssetMark Financial Holdings, Inc. in Q4 2021 and held it in 1 quarter.
Pluribus Labs's AssetMark Financial Holdings, Inc. position peaked at $372K in Q4 2021.
87 funds tracked by Wall St. Rank held AssetMark Financial Holdings, Inc. as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.